diabetestalk.net

Non Invasive Glucose Monitor 2016

Non-invasive Blood Glucose Monitor Uses Microwaves To Sample Blood

Non-invasive Blood Glucose Monitor Uses Microwaves To Sample Blood

Non-Invasive Blood Glucose Monitor Uses Microwaves to Sample Blood At Cardiff University inWales, UK, researchers have developed a blood glucose sensor that doesnt need to sample blood directly every time it performs a measurement. This may mean that the days of lancing fingers to get a drop of blood are close to an end, given that the technology proves itself and gains regulatory approvals. How the technology works is not really clear. But what we know is that the device sends out microwaves and evaluates the returning signal. The microwaves are actually quite weak, produced at energy levels considerably lower than the radio wavesa typical cellphone emits. The device does require the drawing of blood to initially calibrate it for each user, but following that it simply sticks to the skin and every once in a while performs a test. Fifty patients have already participated in an initial assessment of the device, with more trials expected to begin in the coming months. This is certainly exciting for the field of diabetes, as pin pricks are probably the #1 cause of patients not performing regular blood glucose testing. At Medgadget, we report on the latest medical technology news, interview leaders in the field, and file dispatches from medical events from around the world. 13aprallday14alldayWorld Congress On Cancer Science And Therapy, 2018Chicago, IL, USA PULSUS brings in a new spin on conferences by presenting the latest scientific improvements in your field. Listen to motivating keynotes from thought leaders, or rub elbows with pioneers across PULSUS brings in a new spin on conferences by presenting the latest scientific improvements in your field. Listen to motivating keynotes from thought leaders, or rub elbows with pioneers across the globe. Chicago is all set for Continue reading >>

Non-invasive Glucose Monitoring For Diabetes: Five Strategies Under Development

Non-invasive Glucose Monitoring For Diabetes: Five Strategies Under Development

People with diabetes must regularly check their blood glucose levels to know how much medication to use, or to keep track of fluctuating levels. This monitoring is generally done at home using a finger prick blood test. Although accurate, this test can be messy and inconvenient, and there are concerns that many patients are not testing themselves as frequently as they should. A simple, pain-free, non-invasive method would mark a major improvement in diabetes care. Various companies and research groups are working on methods to detect glucose levels in other bodily fluids. Nearly four million people in the UK have been diagnosed with diabetes — about 10% with type 1, and the rest with type 2. Worldwide, about 415 million adults are living with diabetes, according to the International Diabetes Federation. People with type 1 diabetes may be advised to test their blood-sugar levels four to eight times a day; with type 2 diabetes, the recommended frequency of testing varies, but it may be once a day or more. The first blood glucose monitors came to market in the 1970s. Since then, while there have been improvements in the technology, “we’ve not had any successful alternative provided at all”, notes Richard Guy, a pharmaceutical scientist at the University of Bath. A number of barriers exist to self-testing using current methods. “The reasons [people] don’t do it are that it’s painful, it’s messy, it’s often inconvenient, because of whatever situation they happen to be in, or perhaps they feel intimidated about doing it,” says Guy. “Whenever you talk to diabetics, particularly type 1s who have had it for years and really need to test themselves frequently, they are desperate to find an alternative that is discreet and doesn’t involve all the parapherna Continue reading >>

Noninvasive Glucose Monitors Market 2016 - What Are The Commercialization Prospects Of The Noninvasive Glucose Monitors - Research And Markets

Noninvasive Glucose Monitors Market 2016 - What Are The Commercialization Prospects Of The Noninvasive Glucose Monitors - Research And Markets

Noninvasive Glucose Monitors Market 2016 - What are the commercialization prospects of the noninvasive glucose monitors - Research and Markets Research and Markets has announced the addition of the "Noninvasive Glucose Monitors" report to their offering. For diabetes patients, glucose monitoring is a way of life, a several-times-per-day routine critical to physiological health. But while the traditional finger prick method has been a standard disease management tool for decades, issues of patient compliance and the limitations of current methods in detecting short-term fluctuations in glucose levels have brought a host of companies into the hunt for less invasive and more user-friendly alternatives. Now the convergence of small-scale electronics and sophisticated biocompatible product designs is giving hope for a better future to millions of diabetes patients worldwide. Noninvasive glucose monitors that can measure glucose levels accurately and reliably have the capability to improve glycemic control and patient wellbeing. By integrating the sensing element, electronics, and a power source in a single package, noninvasive monitors are creating new options for caregivers and their diabetes patients. Signal processing improvements - include improved signal-to-noise ratios and interference filtering - will continue to be critical to the commercialization prospects of noninvasive monitors. - What are the noninvasive monitoring technologies and devices that are moving toward commercialization and that are expected to have an impact on the diabetes management market by the end of the decade? - What are the products currently under development, and what is their current status in terms of market readiness and product validation? - What are the signification product developmen Continue reading >>

Bme100 F2016:group12 W1030am L1

Bme100 F2016:group12 W1030am L1

Type 2 diabetes is a health issue that effects about 27.84 million people in the United States,1 or about 9.3% of the population.11 Type 2 diabetes develops either when the body is unable to produce the necessary insulin to lower blood glucose levels or when the body has developed resistance to insulin. The main causes of type 2 diabetes are thought to be lack of exercise, unhealthy eating habits, and obesity.2 Diabetes is a severe medical problem because it can lead to blindness, nerve and kidney disorders, and an increased risk for heart disease.11 Another side effect of diabetes is hypoglycemia, which can lead to seizures, unconsciousness, and death.11 The CDC reports that the total cost of diabetes in the United States in 2012 was $245 billion.11 This included costs directly related to the treatment of the disease, as well as indirect costs (those associated with disability, work loss, and premature death). Obviously, this is a huge market size, and a health issue in which we can make a big difference in people's lives. There are several different types of systems available for people with diabetes to monitor their blood glucose levels. The first is the most common and the traditional method of pricking the finger and placing a small drop of blood on a test strip. The second method involves placing a patch on the body that would be in contact with the blood stream at all times. The third method of testing blood glucose levels is using devices that are noninvasive. The advantages and disadvantages of each will be evaluated below: Can only be monitored on a separate device Patches could cause risk for damage if they are elevated above skin level Noninvasive products are not yet available. They are still in development phases and not yet ready for testing. Cloud stora Continue reading >>

The Accuracy Of A Non-invasive Glucose Monitoring Device Does Not Depend On Clinical Characteristics Of People With Type 2 Diabetes Mellitus

The Accuracy Of A Non-invasive Glucose Monitoring Device Does Not Depend On Clinical Characteristics Of People With Type 2 Diabetes Mellitus

The accuracy of a non-invasive glucose monitoring device does not depend on clinical characteristics of people with type 2 diabetes mellitus We are experimenting with display styles that make it easier to read articles in PMC. The ePub format uses eBook readers, which have several "ease of reading" features already built in. The ePub format is best viewed in the iBooks reader. You may notice problems with the display of certain parts of an article in other eReaders. Generating an ePub file may take a long time, please be patient. The accuracy of a non-invasive glucose monitoring device does not depend on clinical characteristics of people with type 2 diabetes mellitus Tamar Lin, Yulia Mayzel, and Karnit Bahartan Objective: GlucoTrack is a non-invasive device that indirectly measures glucose fluctuation in the earlobe tissue. Thus, its accuracy may be subjected to a time lag between glucose concentration in blood and tissue. This time lag was shown to depend on individual characteristics related to microvascular complications, such as diabetes duration, HbA1c level, and smoking history. Therefore, the current study investigated the effects of these factors on GlucoTrack performance. Research design and methods: Clinical trials were conducted on 114 people with type 2 diabetes. Device performance was clinically evaluated using Clarke error grid (CEG) analysis and numerically evaluated using the distribution of absolute relative difference (ARD) values. Results: CEG analysis revealed that 98.0% of glucose readings were within the clinically acceptable CEG A + B zones. Total mean ARD was 22.7%. Clinical and numerical accuracies were comparable between never smokers and former/current smokers, but slightly reduced in the HbA1c 7.5% group and in the diabetes duration 15 year Continue reading >>

Top 3 Non Invasive Glucose Meters 2016

Top 3 Non Invasive Glucose Meters 2016

Here’s the latest on the Top 3 Non Invasive Glucose Monitors 2016 The routine activity of pricking fingers to monitor blood glucose levels is quite hectic for most people with diabetes. Despite this dreadful daily process, the management and control of diabetes is very important. Fortunately, new glucose meters that don’t require blood, for checking blood glucose levels are being developed by numerous companies around the globe, as we speak – welcome relief for many, many diabetes sufferers. FreeStyle Libre FreeStyle Libre by Abbott is an entirely new glucose monitoring concept that provides much greater data than CGM (continuous glucose monitors). The readings are provided by simply scanning a sensor instead of pricking your finger. Main advantages of FreeStyle Libre Lightweight and compact to carry around It provides a graph of how glucose levels are varying just like a CGM (Continuous Glucose Monitor) Users can see how much results are trending downwards or upwards by simply scanning the sensor. The FreeStyle Libre sensor is waterproof for 30 minutes in up to 1 meter. More affordable than continuous glucose monitors. The backlit color touch screen can be read in the dark One of the main benefits of FreeStyle Libre is that it stores up to 90 days of data and you can easily analyze your glucose trend over three months. See the latest news and Approvals for Freestyle Libre USA. Here For Freestyle Libre Australia Updates, Click Here. GlucoWise GlucoWise allows the concentration of blood sugar to be measured at the blood capillary level. Blood glucose levels are measured by a non-invasive technique by transmitting low-power radio waves (65 GHz) sections of the body such as the earlobe or between the forefinger and thumb. Besides having adequate blood supply, the tis Continue reading >>

Noninvasive Blood Glucose Monitoring Device For People With Diabetes In Development

Noninvasive Blood Glucose Monitoring Device For People With Diabetes In Development

Noninvasive blood glucose monitoring device for people with diabetes in development November 14, 2016, American Association of Pharmaceutical Scientists People with diabetes are one step closer to more easily checking their blood glucose levels with a non-invasive device for detecting and monitoring blood glucose levels, which is currently in development. The hand-held breathalyzer device detects acetone, which has been linked to high blood glucose levels in the breath. The research is being presented at the 2016 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition, the world's largest pharmaceutical sciences meeting. The meeting is taking place in Denver Nov. 13-17. Although testing technology has improved in recent decades, with the finger stick testing, as many as 67 percent of people with diabetes may not comply because it is invasive and somewhat painful. Yet, lack of blood-glucose monitoring can result in serious diabetes-related complications. For example, if a person's blood glucose is too low, complications can include seizures, loss of consciousness, and even death. If a person's blood glucose is too high, complications can include infections, cardiovascular disease and nerve and kidney damage. "We believe this technology will be a great improvement in the lives of people with diabetes," said Priefer. "It is the first non-invasive medical device for detecting and monitoring diabetes by connecting one's acetone levels with their blood glucose. We believe it is a necessary alternative to the finger-prick approach for people living with type 1 and type 2 diabetes." Ronny Priefer, Ph.D. and his colleague, Michael Rust, Ph.D., both out of Western New England University in Springfield, Mass., have developed a devicecurrently the si Continue reading >>

Imagine Living A Healthier Life With Glucowise™

Imagine Living A Healthier Life With Glucowise™

We are developing a new non-invasive glucose monitor that will help you take control of your life. (Caution: GlucoWise is still under development and not available for public testing. If you are interested please use the "Get involved" signup form on this page. Due to the overwhelming demand we are unable to respond to individual emails - we are focused on getting the device to the market quickly). Glucowise™ is a non-invasive, 100% pain-free device that makes traditional blood sampling a thing of the past. Our unique sensor technology will allow you to monitor blood glucose levels without the need to pierce your skin. Simple yet highly reliable, Glucowise™ will exceed industry standards for self-monitoring blood glucose accuracy. You will be able to sample as often as you like and wherever you like, ensuring you avoid sudden hypoglycemic events. Our App and Smart Cloud technology delivers personalised advice and alerts, helping you to fully manage your condition. Intelligent analytics will use your current and historical data to calculate and forecast immediate trends in your blood glucose levels, allowing you to adjust your food or medication intake according to your activities or how you are feeling. Glucowise™ will offer unlimited testing without the need for costly consumables, so you can test as often as you like without having to worry about the cost or pain. The compact design will offer you high levels of privacy. It will take no more than 10 seconds to provide a simple, fast and highly discrete testing experience – anytime, anywhere. The data can then sent wirelessly and securely to your smartphone or tablet. Take control There are many situations whereby conventional testing is challenging. Often people with diabetes will unnecessarily expose themselv Continue reading >>

Glucose Monitoring Devices Markets 2016-2024: Self Glucose Monitoring (blood Glucose Strips, Blood Glucose Meters, & Lancets) & Continuous Glucose Monitoring - Global Strategic Business Report 2017

Glucose Monitoring Devices Markets 2016-2024: Self Glucose Monitoring (blood Glucose Strips, Blood Glucose Meters, & Lancets) & Continuous Glucose Monitoring - Global Strategic Business Report 2017

Glucose Monitoring Devices Markets 2016-2024: Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, & Lancets) & Continuous Glucose Monitoring - Global Strategic Business Report 2017 Dublin, Feb. 06, 2018 (GLOBE NEWSWIRE) -- The "Glucose Monitoring Devices - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. This report analyzes the worldwide markets for Glucose Monitoring Devices in US$ by the following Product Segments: Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, & Lancets) The report profiles 77 companies including many key and niche players such as: Glucose Monitoring Devices: Enabling Easier and Efficient Monitoring of the Global Diabetes Epidemic Glucose Monitoring Undergoes Notable Transformation over the Years: An Evolutionary Scan Evolution of Diabetes Testing over the Years with Key Features in Each Period Diabetes Incidence Reaching Epidemic Proportions Worldwide: Foundation for Market Growth Diabetes: One of the Leading Causes of Death Globally Diabetes Incidence and Prevalence by Region/Country Developed Countries are Dominant Markets, while Developing Countries Spearhead Market Growth China: A High Potential Market for Glucose Monitoring Devices Rising Diabetic Populace Spurs Growth in the Indian Market The Big Four' Dominate the Global Self Glucose Monitoring (SGM) Market Major Pharma Players Dominate Blood Glucose Monitorin Continue reading >>

Noninvasive Blood Glucose Monitoring Device For People With Diabetes In Development

Noninvasive Blood Glucose Monitoring Device For People With Diabetes In Development

Noninvasive blood glucose monitoring device for people with diabetes in development Novel breathalyzer offers alternative to finger stick testing for people with type 1 and 2 diabetes American Association of Pharmaceutical Scientists DENVER (Nov. 14, 2016) -- People with diabetes are one step closer to more easily checking their blood glucose levels with a non-invasive device for detecting and monitoring blood glucose levels, which is currently in development. The hand-held breathalyzer device detects acetone, which has been linked to high blood glucose levels in the breath. The research is being presented at the 2016 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition, the world's largest pharmaceutical sciences meeting. The meeting is taking place in Denver Nov. 13-17. Although testing technology has improved in recent decades, with the finger stick testing, as many as 67 percent of people with diabetes may not comply because it is invasive and somewhat painful. Yet, lack of blood-glucose monitoring can result in serious diabetes-related complications. For example, if a person's blood glucose is too low, complications can include seizures, loss of consciousness, and even death. If a person's blood glucose is too high, complications can include infections, cardiovascular disease and nerve and kidney damage. "We believe this technology will be a great improvement in the lives of people with diabetes," said Priefer. "It is the first non-invasive medical device for detecting and monitoring diabetes by connecting one's acetone levels with their blood glucose. We believe it is a necessary alternative to the finger-prick approach for people living with type 1 and type 2 diabetes." Ronny Priefer, Ph.D. and his colleague, Michael Rust, Ph.D. Continue reading >>

Funding Raised Towards Development Of First Non-invasive Glucose Monitor

Funding Raised Towards Development Of First Non-invasive Glucose Monitor

Funding Raised Towards Development of First Non-Invasive Glucose Monitor Nathalie Godthaab Business Development Manager RSP Systems A/S, the technology leaderwithinnon-invasive glucose monitoring, announced completion ofan EUR 4.6m Series A funding. The round was led by Prof. Dr. h.c. Roland Berger, who also joins the Board of Directors of RSP Systems. All of the companys present investors also participated in this round. The proceeds accelerate the companys development of our device, which we believe will bethe worlds first accurate, non-invasive glucose monitor for diabetics, based on RSPs proprietary and clinically validated technology, Critical Depth Raman Spectroscopy. Therefore, and in preparation of the market entry of our deviceRSP Systems is reinforcing its team of staff. Staff is enhanced in the areas of quality assurance, regulatory affairs, product development, and business development. Noteworthy, RSP Systems now expands its clinical testing activities. Extensive clinical studies are initiated in collaboration with Odense University Hospital, a leading Danish hospital in the field of diabetes care and research. The clinical study will run until the end of 2016. It will further demonstrate the accuracy of RSP Systems 3rdgeneration prototypeon an out-patient group size. A second study on diabetes in-patients is set to begin in H2 2016 at a diabetes clinic in Germany. Roland Berger states: "RSP Systems has developed a technology at the intersection of medicine, physics, and engineering. It will improve the lives of millions of diabetic patients. Additional applications of the companys technology could make RSP Systems a key player in the non-invasive diagnostics industry in the future. I am very proud to support a venture that shapes diabetes diagnostics and Continue reading >>

Will The Noninvasive Glucose Monitoring Revolution Ever Arrive?

Will The Noninvasive Glucose Monitoring Revolution Ever Arrive?

A needle-free alternative to the finger-prick test would be a godsend for many sufferers of diabetes, but the industry has yet to clear the technological hurdles. In the early 2000s, a long-standing problem affecting diabetes sufferers around the world seemed on the brink of being solved. After years of research and development, a needle-free device to measure a person’s blood glucose levels was coming to market—a game-changer for patients fed up with the messy and painful procedure of the blood-drawing finger-prick test. Worn like a wristwatch, Cygnus Incorporated’s GlucoWatch G2 Biographer used weak electric currents to draw glucose from interstitial fluid just under the surface of the skin into an “autosensor.” There, the sugar was oxidized by an enzyme, resulting in the release of hydrogen peroxide that was detected by a metal biosensor. The signal produced by this biosensor could be used, the company claimed, to infer how much glucose was in the fluid, and therefore, after a bit more analysis, in the blood. Approved by the US Food and Drug Administration (FDA) in 2002, the device was intended to provide regular, painless measurements and, at least initially, complement, rather than entirely replace, the finger-prick test used by both type 1 and type 2 diabetics. Nevertheless, the excitement was tangible. The Daily Mail labeled the device “a wristwatch to ease diabetes.” The acting principal deputy commissioner of the FDA called the technology “one of the first steps in developing new products that may one day completely eliminate the need for daily finger-prick tests.” Within months of its release, however, the GlucoWatch gained a bad reputation. Patients reported painful rashes where electrical currents irritated the skin, and the device’s thre Continue reading >>

New Glucose Monitor Will Talk To Your Smartphone

New Glucose Monitor Will Talk To Your Smartphone

We're sorry, an error occurred. We are unable to collect your feedback at this time. However, your feedback is important to us. Please try again later. Here's a product description for you: an accurate, non-invasive continuous glucose monitor that talks to your iPhone, and will call someone if the CGM alarms and you don't respond. Sounds like something you might have heard about in our annual DiabetesMine Design Contest , isn't it? Well, guess again! It's a product actually under production by the folks at C8 MediSensors , a San Jose-based company. If you're wondering why you've never heard of them, C8 MediSensors has been in "stealth mode" since 2003, working on a device that monitors blood sugar using a sensor that never punctures the skin. Sounds too good to be true, we know. But after a conversation with Doug Raymond, Vice President of Marketing and Sales, we're truly optimistic. The device, called the HG1-c (which we admit is NOT a very catchy name), is a small unit weighing 5 ounces that fits in the palm of your hand. It's worn on a belt around the waist. Rather than puncturing the skin, the sensor sits close against the skin, and small drop of gel helps to seal any air gaps. The technology behind the HG1-c is complicated, but in a nutshell: a special camera, called a raman spectrometer , inside the sensor uses light to identify and analyze glucose molecules under the skin, via interstitial fluid. Each glucose molecule has a special "signature" the sensor identifies, and from there, analyzes and extrapolates a glucose value, which is transmitted via Bluetooth to a handheld device, like an iPhone or Android, or to a computer. Here's an overview video that C8 MediSensors shared at the recent EASD conference in Portugal: Before we get into the nitty-gritty details o Continue reading >>

Handheld Breathalyzer As Noninvasive Blood Glucose Monitor In Development

Handheld Breathalyzer As Noninvasive Blood Glucose Monitor In Development

Researchers from the Western New England University developed a device the size of a small book that diabetes patients can use to monitor their blood glucose levels. Unlike traditional finger-stick testing, this minimally invasive breathalyzer uses acetone levels in patients’ breath to determine blood glucose levels. The team, led by Ronny Priefer and Michael Rust, presented their work at this year’s American Assn. of Pharmaceutical Scientists meeting in Denver. Although finger stick testing has improved in recent years, the team said that as many as 67% of patients with diabetes may not properly monitor their condition because the testing is invasive and can be painful. Keeping a close eye on blood glucose levels is important for diabetic patients, because if someone’s blood glucose is too low, they can endure complications such as seizures, loss of consciousness and even death. “We believe this technology will be a great improvement in the lives of people with diabetes,” Priefer said in prepared remarks. “It is the first non-invasive medical device for detecting and monitoring diabetes by connecting one’s acetone levels with their blood glucose. We believe it is a necessary alternative to the finger-prick approach for people living with type 1 and type 2 diabetes.” The team tested the breathalyzer device in a small, stage I clinical study of 50 participants – 26 people did not have diabetes, 16 had type 2 diabetes and 8 had type 1 diabetes. When patients blow into the device, it immediately takes a reading of the acetone level in their breath which is correlate to a blood glucose level. Early clinical results show clear correlations between blood glucose levels and breath acetone, according to the researchers. The team identified 1 outlier, who is a Continue reading >>

News & Press Releases

News & Press Releases

Integrity Applications Signs Distribution Agreement for Its GlucoTrack Non-Invasive Glucose Monitoring Device in the Netherlands Integrity Applications Signs Distribution Agreement for Its GlucoTrack Non-Invasive Glucose Monitoring Device in the Netherlands Contract Represents Important First Step in European Re-Launch Wilmington, DE and Ashdod, Israel December 28, 2017 Integrity Applications, Inc. (Integrity) (OTCQB: IGAP), innovator of GlucoTrack, a non-invasive device for measuring glucose levels in people with type [] Integrity Applications Announces Re-Order of GlucoTrack Devices Integrity Applications Announces Re-Order of GlucoTrack Devices Wilmington, DE and Ashdod, Israel November 1 2017 Integrity Applications, Inc. (OTCQB: IGAP) (Integrity or the Company), innovator of GlucoTrack, a non-invasive device for measuring glucose levels in people with type 2 diabetes and pre-diabetes, announced that it has received the largest single re-order of [] Integrity Applications Announces Strategic Corporate Update Exhibit 99.2 Integrity Applications Announces Strategic Corporate Update Near-term Priorities Include GlucoTrack Commercialization in Europe and GlucoTrack US FDA Approval Wilmington, DE and Ashdod, Israel, October 23 2017, Integrity Applications, Inc. (OTCQB: IGAP), innovator of GlucoTrack, a non-invasive device for measuring glucose levels in people with Type 2 diabetes, announced a strategic corporate [] A truly non-invasive glucose monitoring device that may improve diabetes management in patients with type 2 diabetes or prediabetes A truly non-invasive glucose monitoring device that may improve diabetes management in patients with type 2 diabetes or prediabetes Wilmington, Delaware, and Ashdod, Israel, September 7, 2017 Integrity Applications, Inc. (OTCQB: Continue reading >>

More in blood sugar